| Combined effects of angiostatin and ionizing radiation in antitumour therapy HJ Mauceri, NN Hanna, MA Beckett, DH Gorski, MJ Staba, KA Stellato, ... Nature 394 (6690), 287-291, 1998 | 860 | 1998 |
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement J Esquivel, R Sticca, P Sugarbaker, E Levine, TD Yan, R Alexander, ... Annals of surgical oncology 14, 128-133, 2007 | 497 | 2007 |
| Spatial and temporal control of gene therapy using ionizing radiation DE Hallahan, HJ Mauceri, LP Seung, EJ Dunphy, JD Wayne, NN Hanna, ... Nature medicine 1 (8), 786-791, 1995 | 414 | 1995 |
| Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012 M Mohiuddin, K Winter, E Mitchell, N Hanna, A Yuen, C Nichols, R Shane, ... Journal of Clinical Oncology 24 (4), 650-655, 2006 | 324 | 2006 |
| Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer G Zhang, P He, H Tan, A Budhu, J Gaedcke, BM Ghadimi, T Ried, ... Clinical cancer research 19 (18), 4983-4993, 2013 | 277 | 2013 |
| A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2 S Yang, P He, J Wang, A Schetter, W Tang, N Funamizu, K Yanaga, ... Cancer research 76 (13), 3838-3850, 2016 | 263 | 2016 |
| TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors N Senzer, S Mani, A Rosemurgy, J Nemunaitis, C Cunningham, C Guha, ... Journal of clinical oncology 22 (4), 592-601, 2004 | 238 | 2004 |
| Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in … K Turaga, E Levine, R Barone, R Sticca, N Petrelli, L Lambert, G Nash, ... Annals of surgical oncology 21, 1501-1505, 2014 | 234 | 2014 |
| DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma G Zhang, A Schetter, P He, N Funamizu, J Gaedcke, BM Ghadimi, T Ried, ... PloS one 7 (2), e31507, 2012 | 230 | 2012 |
| Colon and rectum JM Jessup, RM Goldberg, EA Asare, AB Benson, JD Brierley, GJ Chang, ... AJCC cancer staging manual, 251-274, 2016 | 226 | 2016 |
| Cancer caregiving and subjective stress: a multi‐site, multi‐dimensional analysis JE Gaugler, N Hanna, J Linder, CW Given, V Tolbert, R Kataria, ... Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2005 | 217 | 2005 |
| Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers M Mohiuddin, M Hayne, WF Regine, N Hanna, PF Hagihara, P McGrath, ... International Journal of Radiation Oncology* Biology* Physics 48 (4), 1075-1080, 2000 | 207 | 2000 |
| Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers S Yovino, M Poppe, S Jabbour, V David, M Garofalo, N Pandya, ... International Journal of Radiation Oncology* Biology* Physics 79 (1), 158-162, 2011 | 180 | 2011 |
| The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: analysis of the National Cancer Data Base EA Asare, CC Compton, NN Hanna, LA Kosinski, MK Washington, ... Cancer 122 (2), 213-221, 2016 | 165 | 2016 |
| Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer N Hanna, P Ohana, FM Konikoff, G Leichtmann, A Hubert, L Appelbaum, ... Cancer gene therapy 19 (6), 374-381, 2012 | 165 | 2012 |
| Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery SC Katz, GR Point, M Cunetta, M Thorn, P Guha, NJ Espat, C Boutros, ... Cancer gene therapy 23 (5), 142-148, 2016 | 159 | 2016 |
| EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study JR Hecht, JJ Farrell, N Senzer, J Nemunaitis, A Rosemurgy, T Chung, ... Gastrointestinal endoscopy 75 (2), 332-338, 2012 | 159 | 2012 |
| Tumor necrosis factor α (TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculature HJ Mauceri, NN Hanna, JD Wayne, DE Hallahan, S Hellman, ... Cancer research 56 (19), 4311-4314, 1996 | 158 | 1996 |
| Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma HR Alexander Jr, DL Bartlett, JF Pingpank, SK Libutti, R Royal, ... Surgery 153 (6), 779-786, 2013 | 147 | 2013 |
| Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal … N Funamizu, C Hu, C Lacy, A Schetter, G Zhang, P He, J Gaedcke, ... International journal of cancer 132 (4), 785-794, 2013 | 140 | 2013 |
